New CEO Mortazavi takes UK biotech e-therapeutics into gene ...

UK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen to spearhead the next stage in the company’s development into gen

Novo extends R&D alliance with AI specialist e-Therapeutics

Novo begins R&D tie-up with AI biotech e-Therapeutics

Novo Nordisk has signed a deal with UK biotech e-Therapeutics to use its AI-based drug discovery technology to find new therapies for type 2 diabetes.

e-Therapeutics and C4XD research Parkinson's drugs

UK biotech e-Therapeutics is to work with genomics firm C4X Discovery to develop new therapies for Parkinson’s disease.

e-Therapeutics CEO steps down

The founder and CEO of UK biotech e-Therapeutics has stood down, as part of restructuring following the failure of a key depression drug earlier this year.